Paris, France

François Radvanyi

This inventor holds 2 USPTO granted patents and 3 published patent applications and 4 EPO patents. Top assignees: Deutsches Krebsforschungszentrum, Institut Curie. Active years: 2017-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: François Radvanyi. Retrieved from https://idiyas.com/inventor/françois-radvanyi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: François Radvanyi: Innovator in Cancer Prediction

Introduction

François Radvanyi is a notable inventor based in Paris, France. He has made significant contributions to the field of cancer prediction, particularly in bladder cancer. With a total of 2 patents, his work focuses on innovative methods for predicting cancer recurrence.

Latest Patents

Radvanyi's latest patents include a groundbreaking method for predicting the risk of recurrence of bladder cancer. This invention involves determining the amount of specific biomarkers in tissue samples and comparing these amounts to reference values. The method aims to identify patients who may require further therapy after initial treatment. Additionally, his patents encompass diagnostic devices and kits designed to facilitate these predictive methods.

Career Highlights

Throughout his career, François Radvanyi has worked with prestigious organizations such as the Deutsches Krebsforschungszentrum and Institut Curie. His experience in these institutions has allowed him to collaborate with leading experts in the field of cancer research.

Collaborations

Some of Radvanyi's notable coworkers include Christoph Schröder and Harish Srinivasan. Their collaborative efforts have contributed to advancements in cancer prediction methodologies.

Conclusion

François Radvanyi's innovative work in cancer prediction exemplifies the impact of research and invention in the medical field. His contributions continue to pave the way for improved patient outcomes in bladder cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…